Pharma Maintains Steady Pace Of IND Submissions in 2005, Parexel Says
Executive Summary
Oncologics led the pharmaceutical industry's investigational new drug application submissions over other drug classes in fiscal year 2005, according to an analysis by Parexel
You may also be interested in...
Pharma’s Pipeline Getting Fuller; Parexel Finds 8.2% Jump In Trial Starts
While pharmaceutical companies have been bemoaning the dearth of new drugs coming on the market, things may be looking up
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011